MRE-269

• Target:

  Prostaglandin Receptor

• Related Pathways:

  Immunology/Inflammation|||GPCR/G Protein

• Purity:

  0.9957

• Bioactivity:

  MRE-269 (ACT-333679) is an orally available and long-acting prostacyclin receptor agonist prodrug. MRE-269 (ACT-333679) is used for the treatment of pulmonary arterial hypertension. MRE-269 (ACT-333679) is an active metabolite of Selexipag (S253150) .

• Smiles:

  N (CCCCOCC (O) =O) (C (C) C) C=1N=C (C (=NC1) C2=CC=CC=C2) C3=CC=CC=C3

• Molecular Formula:

  C25H29N3O3

• Molecular Weight:

  419.52

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  475085-57-5